Shanghai Junshi Biosciences Co (FRA:8SJ) Change In Receivables : €0.0 Mil (TTM As of Jun. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Shanghai Junshi Biosciences Co Change In Receivables?

Shanghai Junshi Biosciences Co's change in receivables for the quarter that ended in Jun. 2024 was €0.0 Mil. It means Shanghai Junshi Biosciences Co's Accounts Receivable stayed the same from Mar. 2024 to Jun. 2024 .

Shanghai Junshi Biosciences Co's change in receivables for the fiscal year that ended in Dec. 2023 was €-34.1 Mil. It means Shanghai Junshi Biosciences Co's Accounts Receivable increased by €34.1 Mil from Dec. 2022 to Dec. 2023 .

Shanghai Junshi Biosciences Co's Accounts Receivable for the quarter that ended in Jun. 2024 was €57.6 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Shanghai Junshi Biosciences Co's Days Sales Outstanding for the three months ended in Jun. 2024 was 101.30.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Shanghai Junshi Biosciences Co's liquidation value for the three months ended in Jun. 2024 was €-58.7 Mil.

Shanghai Junshi Biosciences Co Change In Receivables Historical Data

The historical data trend for Shanghai Junshi Biosciences Co's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Junshi Biosciences Co Change In Receivables Chart

Shanghai Junshi Biosciences Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

-20.21

-64.44

-87.41

131.54

-34.08

Shanghai Junshi Biosciences Co Quarterly Data
	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Mar23	Jun23	Dec23	Mar24	Jun24	Sep24
Change In Receivables	Get a 7-Day Free Trial														-	-	-	-	-

Shanghai Junshi Biosciences Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.0 Mil.

Shanghai Junshi Biosciences Co (FRA:8SJ) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Shanghai Junshi Biosciences Co's Days Sales Outstanding for the quarter that ended in Jun. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	57.612	/	51.895	*	91
=	101.30

2. In Ben Graham's calculation of liquidation value, Shanghai Junshi Biosciences Co's accounts receivable are only considered to be worth 75% of book value:

Shanghai Junshi Biosciences Co's liquidation value for the quarter that ended in Jun. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	424.05	-	561.451	+	0.75 * 57.612	+	0.5 * 70.956
=	-58.7

Shanghai Junshi Biosciences Co Change In Receivables Related Terms

Thank you for viewing the detailed overview of Shanghai Junshi Biosciences Co's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai Junshi Biosciences Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shanghai Junshi Biosciences Co Ltd (FRA:8SJ) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

SHJBF:USA 01877:Hong Kong 688180:China

Address

Nos. 36 and 58, Hai Qu Road, Room 1003, Level 10, Building 2, Pilot Free Trade Zone, Shanghai, CHN

Website

https://www.junshipharma.com

Shanghai Junshi Biosciences Co Ltd is a China-based biotechnology companyy with all-round capabilities in innovative drug discovery and development, clinical research on a global scale, large-scale production capacity to commercialization on the full industry chain. Aiming to develop first-in-class or bestin-class drugs by way of original innovation and co-development. Companies operations are located in the PRC and the USA.

Shanghai Junshi Biosciences Co Headlines

No Headlines